Insulet | PODD - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Align Technology USD 16.04M 14.04M 2025-12
AtriCure USD 1.37M 42K 2025-12
Avanos Medical USD 1.9M 100K 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 149M 4M 2026-03
Boston Scientific USD 90M 0 2026-03
Cardinal Health USD 101M 13M 2026-03
Cooper Companies USD 20.9M 1.5M 2026-03
Dexcom USD 4.2M 500K 2025-12
Edwards Lifesciences USD 35.9M 2.7M 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Globus Medical USD 5.44B 5.44B 2026-03
ICU Medical USD 20.64M 21.39M 2025-12
Inogen 1.03M 384K 2025-03
Insulet USD 14.7M 5.5M 2026-03
Integra LifeSciences USD 22.46M 1.21M 2026-03
J&J USD 43M 25M 2026-03
Masimo USD 6.1M 1.4M 2026-03
Medtronic USD 176M 5M 2026-03
Merit Medical Systems USD 6.53M 162K 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Solventum Corp USD 14.1B 14.05B 2026-03
Stryker USD 46.29B 45.68B 2026-03
Tandem Diabetes Care USD 1.15B 1.15B 2026-03
Teleflex USD 25.72M 2.43M 2026-03
West Pharmaceutical Services USD 1.9M 1.7M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03